Literature DB >> 34050707

Syndromic neurodevelopmental disorder associated with de novo variants in DDX23.

William Burns1, Lynne M Bird2,3, Delphine Heron4, Boris Keren4, Divya Ramachandra5, Isabelle Thiffault6,7, Florencia Del Viso6, Shivarajan Amudhavalli8, Kendra Engleman8, Ilaria Parenti9, Frank J Kaiser9, Jolanta Wierzba10, Korbinian M Riedhammer11,12, Susanne Liptay13, Neda Zadeh14,15, Joseph Porrmann16, Andrea Fischer16, Sophie Gößwein16, Heather M McLaughlin17, Aida Telegrafi18, Katherine G Langley18, Richard Steet1, Raymond J Louie1, Michael J Lyons1.   

Abstract

The DEAD/DEAH box RNA helicases are a superfamily of proteins involved in the processing and transportation of RNA within the cell. A growing literature supports this family of proteins as contributing to various types of human disorders from neurodevelopmental disorders to syndromes with multiple congenital anomalies. This article presents a cohort of nine unrelated individuals with de novo missense alterations in DDX23 (Dead-Box Helicase 23). The gene is ubiquitously expressed and functions in RNA splicing, maintenance of genome stability, and the sensing of double-stranded RNA. Our cohort of patients, gathered through GeneMatcher, exhibited features including tone abnormalities, global developmental delay, facial dysmorphism, autism spectrum disorder, and seizures. Additionally, there were a variety of other findings in the skeletal, renal, ocular, and cardiac systems. The missense alterations all occurred within a highly conserved RecA-like domain of the protein, and are located within or proximal to the DEAD box sequence. The individuals presented in this article provide evidence of a syndrome related to alterations in DDX23 characterized predominantly by atypical neurodevelopment.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  DDX23; RNA helicase; neurodevelopment

Mesh:

Substances:

Year:  2021        PMID: 34050707     DOI: 10.1002/ajmg.a.62359

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Genome-wide sequencing and the clinical diagnosis of genetic disease: The CAUSES study.

Authors:  Alison M Elliott; Shelin Adam; Christèle du Souich; Anna Lehman; Tanya N Nelson; Clara van Karnebeek; Emily Alderman; Linlea Armstrong; Gudrun Aubertin; Katherine Blood; Cyrus Boelman; Cornelius Boerkoel; Karla Bretherick; Lindsay Brown; Chieko Chijiwa; Lorne Clarke; Madeline Couse; Susan Creighton; Abby Watts-Dickens; William T Gibson; Harinder Gill; Maja Tarailo-Graovac; Sara Hamilton; Harindar Heran; Gabriella Horvath; Lijia Huang; Gurdip K Hulait; David Koehn; Hyun Kyung Lee; Suzanne Lewis; Elena Lopez; Kristal Louie; Karen Niederhoffer; Allison Matthews; Kirsten Meagher; Junran J Peng; Millan S Patel; Simone Race; Phillip Richmond; Rosemarie Rupps; Ramona Salvarinova; Kimberly Seath; Kathryn Selby; Michelle Steinraths; Sylvia Stockler; Kaoru Tang; Christine Tyson; Margot van Allen; Wyeth Wasserman; Jill Mwenifumbo; Jan M Friedman
Journal:  HGG Adv       Date:  2022-04-18

2.  Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1.

Authors:  Chen Zhao; Yingwei Li; Chunping Qiu; Jingying Chen; Huan Wu; Qiuman Wang; Xinyue Ma; Kun Song; Beihua Kong
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

3.  Phenotypes of Cornelia de Lange syndrome caused by non-cohesion genes: Novel variants and literature review.

Authors:  Huakun Shangguan; Ruimin Chen
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

4.  WGCNA combined with GSVA to explore biomarkers of refractory neocortical epilepsy.

Authors:  Rui Zhang; Yan Chen; Jia He; Hai-Yan Gou; Yu-Lan Zhu; Yan-Mei Zhu
Journal:  IBRO Neurosci Rep       Date:  2022-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.